Last Updated:
Access Report
Name Designation Appointment Date Status
Avinash Ramchandra Phadnis

Appointed as Director since February 2008

 Director 06-Feb-2008 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Amita Phadnis Avinash

Appointed as Director since February 2008

 Director 06-Feb-2008 Current

People Timeline

Explore the timeline of key personnel in Axennic Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address Shubhlaxmi Apts., Fpl No. 569/1, Near Shree Clinic, Shivajinagar, Pune City Maharashtra, 411004, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 411004
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Axennic Pharmaceuticals Private Limited?
You can contact Axennic Pharmaceuticals Private Limited through their registered address at Shubhlaxmi Apts., Fpl No. 569/1, Near Shree Clinic, Shivajinagar, Pune City Maharashtra, 411004, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Axennic Pharmaceuticals Private Limited?
The current directors of Axennic Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • AVINASH RAMCHANDRA PHADNIS
  • AMITA PHADNIS AVINASH
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available